PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis is a research paper published in Cancer Discovery (2025). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Swiss Science National Foundation
Grant: 310030L_208130
Swiss Science National Foundation
Grant: IZLCZ0_206083
Swiss Science National Foundation
Grant: CRSII5_205930
Swiss Science National Foundation
Grant: TMCG-3_213736
National Science and Technology Council
Grant: 112-2628-B-016-002
National Science and Technology Council
Grant: 113-2628-B-016-005
Ministry of national defence-medical affair bureau
Grant: MND-MAB-D-112095
swiss science national foundation
Grant: 205930
National Science and Technology Council
Grant: NSTC111-2314-B-182A-160-MY2
National Science and Technology Council
Grant: NSTC112-2628-B-182A-007-MY3
Ministry of education in Taiwan
Grant: MOE-113-YSFMN-1009-001-P1
National Science and Technology Council
Grant: NSTC113-2314-B-182A-068
National Institutes of Health
Grant: R01DK122813
Hong Kong SAR
Grant: 14104820
Swiss National Science Foundation
Grant: 163204
Cancer Research Institute (CRI)
SFU MED Research Promotion Fund
Helmut Horten Stiftung
Helmut Horten Stiftung (Helmut Horten Foundation)
Cancer Research Institute
Swiss Cancer Foundation
Swiss Cancer Foundation (SCF)
FWCI
25.26
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals